Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Paving the Way toward Personalized Medicine: Current Advances and Challenges in Multi-OMICS Approach in Autism Spectrum Disorder for Biomarkers Discovery and Patient Stratification
Areej G. Mesleh, Sara Abdulla, Omar M. A. El‐Agnaf
Journal of Personalized Medicine (2021) Vol. 11, Iss. 1, pp. 41-41
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Modern Biomarkers for Autism Spectrum Disorder: Future Directions
Amanda Jensen, Alison L. Lane, Brianna A. Werner, et al.
Molecular Diagnosis & Therapy (2022) Vol. 26, Iss. 5, pp. 483-495
Open Access | Times Cited: 57
Ratings of the Effectiveness of 13 Therapeutic Diets for Autism Spectrum Disorder: Results of a National Survey
Julie Matthews, James B. Adams
Journal of Personalized Medicine (2023) Vol. 13, Iss. 10, pp. 1448-1448
Open Access | Times Cited: 16
The use of data independent acquisition based proteomic analysis and machine learning to reveal potential biomarkers for autism spectrum disorder
Huajie Zhang, Xiaoxiao Tang, Chengyun Feng, et al.
Journal of Proteomics (2023) Vol. 278, pp. 104872-104872
Closed Access | Times Cited: 14
A Comprehensive Review on Plant-Based Medications and Chemical Approaches for Autism Spectrum Disorders (ASDs) Psychopharmacotherapy
Vrish Dhwaj Ashwlayan, Ratneshwar Kumar Ratnesh, Divya Sharma, et al.
Indian Journal of Microbiology (2024)
Closed Access | Times Cited: 5
Genetics and Epigenetics of One-Carbon Metabolism Pathway in Autism Spectrum Disorder: A Sex-Specific Brain Epigenome?
Veronica Tisato, Juliana Araujo Silva, Giovanna Longo, et al.
Genes (2021) Vol. 12, Iss. 5, pp. 782-782
Open Access | Times Cited: 29
Olink proteomics profiling platform reveals non-invasive inflammatory related protein biomarkers in autism spectrum disorder
Xiaohong Bao, Baofu Chen, Jun Liu, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 11
Integrative approach of omics and imaging data to discover new insights for understanding brain diseases
Jong Hyuk Yoon, Hagyeong Lee, Dayoung Kwon, et al.
Brain Communications (2024) Vol. 6, Iss. 4
Open Access | Times Cited: 4
Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder
Theoharis C. Theoharides
Journal of Personalized Medicine (2021) Vol. 11, Iss. 9, pp. 860-860
Open Access | Times Cited: 22
Combined Plasma Olink Proteomics and Transcriptomics Identifies CXCL1 and TNFRSF12A as Potential Predictive and Diagnostic Inflammatory Markers for Acute Kidney Injury
Xiaoyang Li, Xiangyang Zhou, Xinbo Ping, et al.
Inflammation (2024) Vol. 47, Iss. 5, pp. 1547-1563
Closed Access | Times Cited: 3
Treatment of Autism Spectrum Disorders by Mitochondrial-targeted Drug: Future of Neurological Diseases Therapeutics
Showkat Ul Nabi, Muneeb U. Rehman, Azher Arafah, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 5, pp. 1042-1064
Open Access | Times Cited: 14
A Personalized Approach to Evaluating and Treating Autism Spectrum Disorder
Richard E. Frye, Shannon Rose, Richard G. Boles, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 2, pp. 147-147
Open Access | Times Cited: 12
Integrating Artificial Intelligence and Advanced Genomic Technologies in Unraveling Autism Spectrum Disorder and Gastrointestinal Comorbidities: A Multidisciplinary Approach to Precision Medicine
Lama Ghunaim, Ahmed S.A. Ali Agha, Talal Aburjaı
Jordan Journal of Pharmaceutical Sciences (2024) Vol. 17, Iss. 3, pp. 567-581
Closed Access | Times Cited: 2
Urinary organic acids spectra in children with altered gut microbiota composition and autistic spectrum disorder
Zanda Daneberga, Miki Nakazawa, Egija Berga-Švītiņa, et al.
Nordic Journal of Psychiatry (2021) Vol. 76, Iss. 7, pp. 523-529
Closed Access | Times Cited: 15
Methods to Improve Molecular Diagnosis in Genomic Cold Cases in Pediatric Neurology
Magda K. Kadlubowska, Isabelle Schrauwen
Genes (2022) Vol. 13, Iss. 2, pp. 333-333
Open Access | Times Cited: 10
A molecular framework for autistic experiences: Mitochondrial allostatic load as a mediator between autism and psychopathology
Caitlyn Mahony, Colleen O’Ryan
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 8
Metabolomic biomarkers in autism: identification of complex dysregulations of cellular bioenergetics
Alan M. Smith, Elizabeth L.R. Donley, Denise M. Ney, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 4
Reversal of Autism among Dizygotic Twins through a Personalized Lifestyle and Environmental Modification Approach: A Case Report and Review of the Literature
Christopher R. D’Adamo, Josephine L. Nelson, Sara N. Miller, et al.
(2024)
Open Access | Times Cited: 1
Reversal of Autism Symptoms among Dizygotic Twins through a Personalized Lifestyle and Environmental Modification Approach: A Case Report and Review of the Literature
Christopher R. D’Adamo, Josephine L. Nelson, Sara N. Miller, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 6, pp. 641-641
Open Access | Times Cited: 1
Serum proteome profiling of plateau acclimatization in men using Olink proteomics approach
Jingyu Pan, Yue Dong, Zhihao Zou, et al.
Physiological Reports (2024) Vol. 12, Iss. 24
Open Access | Times Cited: 1
Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study
Areej G. Mesleh, Hanan Ehtewish, Alberto de la Fuente, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7443-7443
Open Access | Times Cited: 3
The diagnostic potential of the epigenome in autism spectrum disorders
Fabio Coppedè
Epigenomics (2021) Vol. 13, Iss. 20, pp. 1587-1590
Closed Access | Times Cited: 5
Glucose and Lipid Profiles Predict Anthropometric Changes in Drug-Naïve Adolescents Starting Treatment with Risperidone or Sertraline: A Pilot Study
Emilia Matera, Gloria Cristofano, Flora Furente, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 48-48
Open Access | Times Cited: 3
Potential approaches and recent advances in biomarker discovery in autism spectrum disorders
Salam Salloum‐Asfar, Ahmed K. Elsayed, Sara Abdulla
Elsevier eBooks (2023), pp. 121-145
Closed Access | Times Cited: 1
Genetics and epigenetics of the one-carbon metabolism pathway in autism spectrum disorder: Role of a sex-specific brain epigenome
Donato Gemmati, Veronica Tisato
Elsevier eBooks (2023), pp. 181-191
Closed Access | Times Cited: 1
Cord Blood Metabolite Profiles and Their Association with Autistic Traits in Childhood
Christin S. Kaupper, Sophia M. Blaauwendraad, Charlotte A. M. Cecil, et al.
Metabolites (2023) Vol. 13, Iss. 11, pp. 1140-1140
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top